U.S. pharma big copyright scrapped two experimental weight loss pills past calendar year—a at the time-day by day capsule, lotiglipron, because of elevated liver enzymes plus a twice-daily tablet, danuglipron, on account of strong Unintended effects—but CEO Albert Bourla has explained the company is set to “Enjoy and win” from the being ove